Back to Search
JAY BERK, PH.D.
PH.D.
Clinical Psychologist
NPI: 1588770622Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
4737(OH)
Research & Publications (20)
Monocyte chemoattractant protein-1 in the choroid plexus: a potential link between vascular pro-inflammatory mediators and the CNS during peripheral tissue inflammation.
PMID 19032979·Neuroscience·2009
7-preclinical
Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy.
PMID 19212660·Int J Mol Med·2009
8-other
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
PMID 17589534·Bone Marrow Transplant·2007
3-trial
Mitosis-specific mechanosensing and contractile-protein redistribution control cell shape.
PMID 17027494·Curr Biol·2006
7-preclinical
[Influence of a turkey stable with a veranda on performance, behaviour and health of male turkeys].
PMID 16669193·Dtsch Tierarztl Wochenschr·2006
7-preclinical
Hypoxia suppresses elastin repair by rat lung fibroblasts.
PMID 16055482·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
PMID 16399645·Amyloid·2005
8-other
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.
PMID 15155460·Blood·2004
3-trial
Semaphorin-plexin signaling guides patterning of the developing vasculature.
PMID 15239959·Dev Cell·2004
7-preclinical
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
PMID 14734330·Ann Intern Med·2004
3-trial
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.
PMID 14676787·Bone Marrow Transplant·2004
3-trial
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.
PMID 12672274·Clin Lymphoma·2003
3-trial
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
PMID 12970025·Chest·2003
8-other
Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill.
PMID 12771607·Crit Care Med·2003
4-observational
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.
PMID 12060126·Br J Haematol·2002
8-other
NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype.
PMID 12055073·Am J Physiol Cell Physiol·2002
7-preclinical
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
PMID 11704785·Bone Marrow Transplant·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 28001 CHAGRIN BLVD, #212
WOODMERE, OH 44122 - Phone
- (216) 292-7170
Quick Facts
- NPI
- 1588770622
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile